Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey R Oxnard

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
The Oncologist|June 3, 2021
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing PatternsMason A Israel, Natalie Danziger, Kimberly A McGregor, et al.
JCO Precision Oncology|January 31, 2024
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to TreatmentAlessandro Russo, Jessica K Lee, Lincoln W Pasquina, et al.
The Lancet. Oncology|December 3, 2014
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trialPasi A Jänne, Sai-Hong I Ou, Dong-Wan Kim, et al.
Cancer Research|June 7, 2015
Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2Junko Tanizaki, Dalia Ercan, Marzia Capelletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2011
EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinomaMai He, Marzia Capelletti, Khedoudja Nafa, et al.
JCO Precision Oncology|July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor EffectivenessJulia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.
Molecular Oncology|November 25, 2022
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumabMaya Kansara, Neeru Bhardwaj, Subotheni Thavaneswaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate CancerAlex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, et al.
JAMA Network Open|January 23, 2023
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational BurdenJulia C F Quintanilha, Ryon P Graf, Virginia A Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer PatientsCloud P Paweletz, Adrian G Sacher, Chris K Raymond, et al.
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
The Oncologist|June 3, 2021
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing PatternsMason A Israel, Natalie Danziger, Kimberly A McGregor, et al.
JCO Precision Oncology|January 31, 2024
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to TreatmentAlessandro Russo, Jessica K Lee, Lincoln W Pasquina, et al.
The Lancet. Oncology|December 3, 2014
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trialPasi A Jänne, Sai-Hong I Ou, Dong-Wan Kim, et al.
Cancer Research|June 7, 2015
Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2Junko Tanizaki, Dalia Ercan, Marzia Capelletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2011
EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinomaMai He, Marzia Capelletti, Khedoudja Nafa, et al.
JCO Precision Oncology|July 6, 2023
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor EffectivenessJulia C F Quintanilha, Michael H Storandt, Ryon P Graf, et al.
Molecular Oncology|November 25, 2022
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumabMaya Kansara, Neeru Bhardwaj, Subotheni Thavaneswaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate CancerAlex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, et al.
JAMA Network Open|January 23, 2023
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational BurdenJulia C F Quintanilha, Ryon P Graf, Virginia A Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer PatientsCloud P Paweletz, Adrian G Sacher, Chris K Raymond, et al.
Pageof 20